{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T22:29:45Z","timestamp":1648938585287},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T00:00:00Z","timestamp":1252540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s00108-009-2376-0","type":"journal-article","created":{"date-parts":[[2009,9,14]],"date-time":"2009-09-14T18:15:47Z","timestamp":1252952147000},"page":"1402-1407","source":"Crossref","is-referenced-by-count":3,"title":["Erniedrigte Knochendichte und Knochenschmerzen"],"prefix":"10.1007","volume":"50","author":[{"given":"H.M.","family":"Findeisen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.J.","family":"Auernhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.G.","family":"Parhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.A.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"la Fougere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Weiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bartl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,10]]},"reference":[{"key":"2376_CR1","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","volume":"21","author":"Burnett","year":"2006","unstructured":"Burnett SA, Gunawardene SC, Bringhurst FR et al. (2006) Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 21: 1187\u20131196","journal-title":"J Bone Miner Res"},{"key":"2376_CR2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","volume":"359","author":"de","year":"2002","unstructured":"de Beur SMJ, Streeten EA, Civelek AC et al. (2002) Localisation of mesenchymal tumours by somatostatin receptor imaging. Lancet 359: 761\u2013763","journal-title":"Lancet"},{"key":"2376_CR3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2005.01.001","volume":"36","author":"Dupond","year":"2005","unstructured":"Dupond JL, Mahammedi H, Prie D et al. (2005) Oncogenic osteomalacia: Diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET\/CT SCAN for the diagnosis and follow-up in one case. Bone 36: 375\u2013378","journal-title":"Bone"},{"key":"2376_CR4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1024\/1019-1291.16.3.207","volume":"16","author":"Fassbender","year":"2007","unstructured":"Fassbender WJ, Brandenburg VM (2007) St\u00f6rungen des Phosphatstoffwechsels. Osteologie 16: 207\u2013222","journal-title":"Osteologie"},{"key":"2376_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"Folpe","year":"2007","unstructured":"Folpe AL, Fanburg-Smith JC, Billings SD et al. (2007) Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28: 1\u201330","journal-title":"Am J Surg Pathol"},{"key":"2376_CR6","doi-asserted-by":"crossref","first-page":"E929","DOI":"10.1152\/ajpendo.90456.2008","volume":"295","author":"Garringer","year":"2008","unstructured":"Garringer HJ, Malekpir M, Esteghamat F et al. (2008) Molecular genetic and biochemical analyses if FGF23 mutations in familial tumoral calcinosis. Am J Physiol Endocrinol Metab 295: E929\u2013E937","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2376_CR7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ncpendmet0639","volume":"3","author":"Halperin","year":"2007","unstructured":"Halperin F, Anderson RJ, Mulder JE (2007) Tumor-induced osteomalacia: the importance of measuring serum phosphorus levels. Nat Clin Pract Endocrinol Metab 3: 721\u2013725","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2376_CR8","first-page":"434","volume":"4","author":"Imel","year":"2007","unstructured":"Imel EA, Econs MJ (2007) Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23. Pediatr Endocrinol Rev 4 (Suppl 4): 434\u2013439","journal-title":"Pediatr Endocrinol Rev"},{"key":"2376_CR9","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/jc.2005-2105","volume":"91","author":"Imel","year":"2006","unstructured":"Imel EA, Peacock M, Pitukcheewanont P et al. (2006) Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab 91: 2055\u20132061","journal-title":"J Clin Endocrinol Metab"},{"key":"2376_CR10","doi-asserted-by":"crossref","unstructured":"Jakob F (2007) Knochenstoffwechselerkrankungen. Internist (Berl) 48: 1101\u20131117","DOI":"10.1007\/s00108-007-1934-6"},{"key":"2376_CR11","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","volume":"294","author":"Jan","year":"2005","unstructured":"Jan de Beur SM (2005) Tumor-induced osteomalacia. JAMA 294: 1260\u20131267","journal-title":"JAMA"},{"key":"2376_CR12","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"Jonsson","year":"2003","unstructured":"Jonsson KB, Zahradnik R, Larsson T et al. (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348: 1656\u20131663","journal-title":"N Engl J Med"},{"key":"2376_CR13","doi-asserted-by":"crossref","first-page":"F1577","DOI":"10.1152\/ajprenal.00463.2006","volume":"293","author":"Perwad","year":"2007","unstructured":"Perwad F, Zhang MYH, Tenenhouse HS et al. (2007) Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1{alpha}-hydroxylase expression in vitro. Am J Physiol Renal Physiol 293: F1577\u2013F1583","journal-title":"Am J Physiol Renal Physiol"},{"key":"2376_CR14","first-page":"611","volume":"114","author":"Pfeilschifter","year":"2006","unstructured":"Pfeilschifter J (2006) DVO-guideline for prevention, diagnosis, and therapy of osteoporosis for women after menopause, for men after age 60. Executive summary guidelines. Exp Clin Endocrinol Diabetes 114: 611\u2013622","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2376_CR15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1521-690X(03)00055-1","volume":"17","author":"Ritz","year":"2003","unstructured":"Ritz E, Haxsen V, Zeier M (2003) Disorders of phosphate metabolism \u2013 pathomechanisms and management of hypophosphataemic disorders. Best Pract Res Clin Endocrinol Metab 17: 547\u2013558","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2376_CR16","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","volume":"345","author":"Seufert","year":"2000","unstructured":"Seufert J, Ebert K, M\u00fcller J et al. (2000) Octreotid therapy for tumor-induced osteomalacia. N Engl J Med 345: 1883\u20131888","journal-title":"N Engl J Med"},{"key":"2376_CR17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y et al. (2004) FGF-23 Is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19: 429\u2013435","journal-title":"J Bone Miner Res"},{"key":"2376_CR18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/MNH.0b013e3282fd6e5b","volume":"17","author":"Strom","year":"2008","unstructured":"Strom TM, J\u00fcppner H (2008) PHEX, FGF23, DMP1 and beyond. Curr Opin Nephrol Hypertens 17: 357\u2013362","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2376_CR19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/EJE-07-0779","volume":"158","author":"van","year":"2008","unstructured":"van Boekel G, Ruinemans-Koerts J, Joosten F et al. (2008) Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling. Eur J Endocrinol 158: 431\u2013437","journal-title":"Eur J Endocrinol"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-009-2376-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-009-2376-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-009-2376-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:12:13Z","timestamp":1558584733000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-009-2376-0"}},"subtitle":["Osteomalazie mit Hypophosphat\u00e4mie und Hyperphosphaturie"],"short-title":[],"issued":{"date-parts":[[2009,9,10]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["2376"],"URL":"https:\/\/doi.org\/10.1007\/s00108-009-2376-0","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,10]]}}}